NCT06893276 e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
| NCT ID | NCT06893276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Pancreatic Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-08-13 |
| Primary Completion | 2027-11-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-08-13 with a primary completion date of 2027-11-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.
Eligibility Criteria
Inclusion Criteria: 1. Greater than 18 years of age. 2. Spanish or English speaker with ability to read one of these languages. 3. Diagnosis of pancreatic cancer. 4. Patients diagnosed with pancreatic neuroendocrine tumor (PNET). Exclusion Criteria: 1. Patients unable to read Spanish or English, as participants will not be unable to complete surveys. 2. Have a history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months). 3. Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.
Contact & Investigator
Frank Penedo, PhD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT06893276 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06893276 currently recruiting?
Yes, NCT06893276 is actively recruiting participants. Contact the research team at sarafleszarpavlovic@med.miami.edu for enrollment information.
Where is the NCT06893276 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT06893276 clinical trial?
NCT06893276 is sponsored by University of Miami. The principal investigator is Frank Penedo, PhD at University of Miami. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.